These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9169662)

  • 1. CD16 antigen density on neutrophils in chronic myeloproliferative disorders.
    Kabutomori O; Iwatani Y; Koh T; Yanagihara T
    Am J Clin Pathol; 1997 Jun; 107(6):661-4. PubMed ID: 9169662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Decrease of CD16 antigen density on granulocytes in chronic myeloid leukemia].
    Kabutomori O; Koh T; Iwatani Y; Fushimi R; Amino N; Miyai K
    Rinsho Byori; 1992 Sep; 40(9):997-8. PubMed ID: 1434038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
    Tefferi A
    Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloperoxidase-deficient polymorphonuclear leucocytes (VII): Incidence in untreated myeloproliferative disorders.
    Bendix-Hansen K
    Scand J Haematol; 1986 Jan; 36(1):8-10. PubMed ID: 3006224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of neutrophil and monocyte oxidative responses in polycythaemia vera and related myeloproliferative disorders.
    Samuelsson J; Forslid J; Hed J; Palmblad J
    Br J Haematol; 1994 Jul; 87(3):464-70. PubMed ID: 7993785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative and functional studies of impaired natural killer (NK) cells in patients with myelofibrosis, essential thrombocythemia, and polycythemia vera. I. A potential role for platelet-derived growth factor in defective NK cytotoxicity.
    Gersuk GM; Carmel R; Pattamakom S; Challita PM; Rabinowitz AP; Pattengale PK
    Nat Immun; 1993; 12(3):136-51. PubMed ID: 8329837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil PRV-1 expression across the chronic myeloproliferative disorders and in secondary or spurious polycythemia.
    Tefferi A; Lasho TL; Wolanskyj AP; Mesa RA
    Blood; 2004 May; 103(9):3547-8. PubMed ID: 14701686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An improved method for biochemical measurement of the activity of neutrophil alkaline phosphatase and its application to myeloproliferative disorders].
    Tokuda M; Kawanishi K; Irino S
    Rinsho Ketsueki; 1991 Aug; 32(8):838-43. PubMed ID: 1942523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil alkaline phosphatase: comparison of enzymes from normal subjects and patients with polycythemia vera and chronic myelogenous leukemia.
    Rosenblum D; Petzold SJ
    Blood; 1975 Mar; 45(3):335-43. PubMed ID: 46759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Planimetric analysis of megakaryocytes in the four main groups of chronic myeloproliferative disorders.
    Nafe R; Georgii A; Kaloutsi V; Fritsch RS; Choritz H
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 61(2):111-6. PubMed ID: 1683718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of beta-catenin in chronic myeloproliferative disorders.
    Jauregui MP; Sanchez SR; Ewton AA; Rice L; Perkins SL; Dunphy CH; Chang CC
    Hum Pathol; 2008 Oct; 39(10):1454-8. PubMed ID: 18619646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow stromal cells in myeloproliferative disorders.
    Hirata J; Takahira H; Kaneko S; Nishimura J; Nawata H
    Acta Haematol; 1989; 82(1):35-9. PubMed ID: 2505472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FcRIII (CD16) expression on neutrophils from chronic myeloid leukemia. A flow cytometric study.
    Carulli G; Gianfaldoni ML; Azzara A; Papineschi F; Vanacore R; Minnucci S; Testi R; Ambrogi F
    Leuk Res; 1992 Dec; 16(12):1203-9. PubMed ID: 1465030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
    Macavei I; Galatâr N
    Morphol Embryol (Bucur); 1989; 35(2):117-27. PubMed ID: 2529429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased neutrophil respiratory burst in myeloproliferative disorders: selective enhancement of superoxide release triggered by receptor-mediated agonists and low responsiveness to in vitro cytokine stimulation.
    Iki S; Yuo A; Yagisawa M; Inuo EK; Inoue Y; Usuki K; Urabe A; Suzuki K; Kitagawa S; Togawa A; Takaku F
    Exp Hematol; 1997 Jan; 25(1):26-33. PubMed ID: 8989903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].
    Iványi JL; Marton E; Plander M
    Orv Hetil; 2011 Nov; 152(45):1795-803. PubMed ID: 22011365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mobilization of granules in neutrophils from patients with myeloproliferative disorders.
    Borregaard N; Kjeldsen L; Sengeløv H
    Eur J Haematol; 1993 Apr; 50(4):189-99. PubMed ID: 8388806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leucocyte alkaline phosphatase identifies terminally differentiated normal neutrophils and its lack in chronic myelogenous leukaemia is not dependent on p210 tyrosine kinase activity.
    Dotti G; Garattini E; Borleri G; Masuhara K; Spinelli O; Barbui T; Rambaldi A
    Br J Haematol; 1999 Apr; 105(1):163-72. PubMed ID: 10233380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
    Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
    Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased leukocyte-platelet adhesion in chronic myeloproliferative disorders with high platelet counts.
    Kaplar M; Kappelmayer J; Kiss A; Szabo K; Udvardy M
    Platelets; 2000 May; 11(3):183-4. PubMed ID: 10938896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.